Author | Study population | Risk factor | Change in risk |
---|---|---|---|
Langer-Gould et al. | n. 75, MS onset < 18 years | BMI | - Overweight x 1.58 - Moderately obese x 1.78 - Extremely obese x 3.76 |
Mikaeloff et al. | n.90, MS onset 10 to <16Â years | Passive smoking | x 2.49 |
Banwell et al. | n. 49, MS onset < 16 years | Remote EBV infection | x 2.58 |
Waubant et al. | n. 189, MS onset < 18 years | Remote EBV infection | x 3.72 |
Disanto et al. | n. 64, MS onset < 16 years | ≥1 HLA-DRB1 alleles | x 3.2 |
McDonald et al. | n. 170, MS onset < 18 years | Salt intake | No effect |
Banwell et al. | n. 63, MS onset < 16 years | Vitamin D increase + 10 nmol/L | 10% reduction |
Monry et al. | n. 110, MS onset ≤ 18 years | Vitamin D increase + 10 nmol/L | 30% reduction |
Waubant et al. | n. 189, MS onset < 18 years | VCM seropositivity | 73% reduction |